1. Home
  2. FOXO vs AIMD Comparison

FOXO vs AIMD Comparison

Compare FOXO & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXO
  • AIMD
  • Stock Information
  • Founded
  • FOXO 2019
  • AIMD 1984
  • Country
  • FOXO United States
  • AIMD United States
  • Employees
  • FOXO N/A
  • AIMD N/A
  • Industry
  • FOXO Retail: Computer Software & Peripheral Equipment
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOXO Technology
  • AIMD Health Care
  • Exchange
  • FOXO Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • FOXO 4.9M
  • AIMD 8.5M
  • IPO Year
  • FOXO N/A
  • AIMD N/A
  • Fundamental
  • Price
  • FOXO $0.24
  • AIMD $0.74
  • Analyst Decision
  • FOXO
  • AIMD
  • Analyst Count
  • FOXO 0
  • AIMD 0
  • Target Price
  • FOXO N/A
  • AIMD N/A
  • AVG Volume (30 Days)
  • FOXO 13.7M
  • AIMD 380.6K
  • Earning Date
  • FOXO 11-19-2024
  • AIMD 03-07-2025
  • Dividend Yield
  • FOXO N/A
  • AIMD N/A
  • EPS Growth
  • FOXO N/A
  • AIMD N/A
  • EPS
  • FOXO N/A
  • AIMD N/A
  • Revenue
  • FOXO $1,341,000.00
  • AIMD $40,633.00
  • Revenue This Year
  • FOXO N/A
  • AIMD N/A
  • Revenue Next Year
  • FOXO N/A
  • AIMD N/A
  • P/E Ratio
  • FOXO N/A
  • AIMD N/A
  • Revenue Growth
  • FOXO 196.03
  • AIMD N/A
  • 52 Week Low
  • FOXO $0.13
  • AIMD $0.40
  • 52 Week High
  • FOXO $1.30
  • AIMD $3.10
  • Technical
  • Relative Strength Index (RSI)
  • FOXO 46.29
  • AIMD 59.44
  • Support Level
  • FOXO $0.20
  • AIMD $0.57
  • Resistance Level
  • FOXO $0.23
  • AIMD $0.77
  • Average True Range (ATR)
  • FOXO 0.02
  • AIMD 0.06
  • MACD
  • FOXO 0.00
  • AIMD -0.00
  • Stochastic Oscillator
  • FOXO 52.70
  • AIMD 68.48

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: